BioCentury
ARTICLE | Company News

NuOncology other research news

April 12, 1999 7:00 AM UTC

NLAB presented data showing that Arglabin inhibits farnesyl transferase, an enzyme involved in post-translational modification and activation of the Ras oncogene. The company said that inhibition of ...